Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Aclidinium bromide

200 micrograms, once daily, 1 day treatment

DRUG

Placebo Tiotropium

1 puff once daily, 1 day treatment

DRUG

Tiotropium

1 puff of 18 µg (22.5 µg tiotropium bromide monohydrate) in the morning between 8:00 and 10:00

DRUG

Placebo LAS34273

1 puff, 1 dat treatment

Trial Locations (1)

W1G 8HU

Respiratory Clinical Trials Ltd, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY